Manager TitleAgeSince
Chief Executive Officer - 2024-03-12
Director TitleAgeSince
Director/Board Member - 2023-06-06
Director/Board Member - 2023-06-06
Date Insider Type Main position Quantity % Market Cap.
12/11/25 Sell 500,000 -
12/11/25 Other

Chief Executive Officer

0 -
12/11/25 Sell

Director

800,000 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 8.49M
+0.34%-1.06%-14.12%-5.48% 13.09B
+0.04%-2.86%-35.89%-58.06% 4.85B
-0.72%-7.55%-7.99%-6.69% 4.59B
-3.71%-6.60%-2.46%-29.63% 4.09B
+1.05%-1.24%-23.25%+3.48% 3.51B
+0.04%-0.45%-11.34%-6.44% 3.34B
-1.00%-3.33%-13.18%+12.27% 3.33B
-2.19%-4.59%-19.98%-16.50% 2.43B
-0.65%-4.13%-30.80%-13.84% 1.67B
Average -0.68%-2.60%-17.67%-13.43% 4.55B
Weighted average by Cap. -0.48%-2.08%-16.36%-13.13%
Logo Orion Nutraceuticals Inc.
Orion Nutraceuticals Inc. is a Canada-based company. The Company is primarily focused on re-purposing a United States food and drug administration approved drug to target asthma and chronic obstructive pulmonary disease (COPD).
Employees
-